Investor Relations

Latest Financial Results

Q1 2022

Quarter Ended Mar 31, 2022

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Company Overview

MyMD, Inc. (NASDAQ: MYMD) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. MyMD is traded on the Nasdaq under the ticker symbol MYMD

Investor Contact Information

Company

MyMD Pharmaceuticals, Inc.
855 N. Wolfe Street
Suite 601
Baltimore, MD 21205

Investor Relations

Robert Schatz
T: 646-421-9523
rschatz@mymd.com

Transfer Agent

Action Stock Transfer
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: 801-274-1088
F: 801-274-1099
https://www.actionstocktransfer.com

  • This field is for validation purposes and should be left unchanged.
-->